Efficacy and Safety of Rifaximin Treatment for Reducing the Risk of Overt Hepatic Encephalopathy by Baseline Hepatic Impairment

被引：0
|
作者：
Flamm, Steven L. [1 ]
Bajaj, Jasmohan S. [2 ,3 ]
Heimanson, Zeev [4 ]
Neff, Guy [5 ]
机构：
[1] Northwestern Feinberg, Sch Med, Chicago, IL USA
[2] Virginia Commonwealth Univ, Richmond, VA USA
[3] McGuire VA Med Ctr, Richmond, VA USA
[4] Salix Pharmaceut, Bridgewater, NJ USA
[5] Florida Digest Hlth Specialists, Florida Res Inst, Lakewood Ranch, FL USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2018年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
829
引用
收藏
页码：S458 / S460
页数：3
相关论文
共 50 条
  • [31] Rifaximin for overt hepatic encephalopathy in real life: effective for prevention but not for cure
    Chautant, Fiona
    Duhalde, Veronique
    Berlioux, Pierre
    Christol, Camille
    Robic, Marie Angele
    Peron, Jean-Marie
    Vinel, Jean-Pierre
    Bureau, Christophe
    HEPATOLOGY, 2013, 58 : 897A - 897A
  • [32] COST EFFECTIVENESS OF RIFAXIMIN-A IN THE REDUCTION OF RECURRENCE OF OVERT HEPATIC ENCEPHALOPATHY
    Poole, C. D.
    Conway, P.
    Nanuwa, K.
    Joseph, B.
    Bannister, C.
    Currie, C. J.
    GUT, 2014, 63 : A191 - A192
  • [33] COST EFFECTIVENESS OF RIFAXIMIN-α IN THE REDUCTION OF RECURRENCE OF OVERT HEPATIC ENCEPHALOPATHY
    Poole, C. D.
    Conway, P.
    Nanuwa, K.
    Joseph, B.
    Bannister, C.
    Currie, C. J.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S219 - S219
  • [34] Rifaximin: A nonabsorbable, broad-spectrum antibiotic for reduction in the risk for recurrence of overt hepatic encephalopathy
    Feret, Brett
    Barner, Benjamin
    FORMULARY, 2010, 45 (07) : 210 - 216
  • [35] Additional L-Carnitine Reduced the Risk of Hospitalization in Patients with Overt Hepatic Encephalopathy on Rifaximin
    Kubota, Kousuke
    Uojima, Haruki
    Shao, Xue
    Iwasaki, Shuichiro
    Hidaka, Hisashi
    Wada, Naohisa
    Nakazawa, Takahide
    Shibuya, Akitaka
    Kako, Makoto
    Koizumi, Wasaburo
    DIGESTIVE DISEASES, 2022, 40 (03) : 313 - 321
  • [36] Rifaximin as Treatment for Hepatic Encephalopathy: Some Considerations
    Ridola, Lorenzo
    Zullo, Angelo
    Hassan, Cesare
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2013, 19 (01): : 56 - 56
  • [37] Cost Effectiveness of Rifaximin in the Treatment of Hepatic Encephalopathy
    Congly, Stephen E.
    Leise, Michael D.
    Kim, W. Ray
    HEPATOLOGY, 2013, 58 : 869A - 869A
  • [38] A Comparison of Rifaximin with Placebo for the treatment of Hepatic Encephalopathy
    Majeed, Abida
    Butt, Mishal Waheed
    Aziz, Hafiza Ayesha
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2018, 12 (01): : 362 - 364
  • [39] Hepatic Encephalopathy Treatment: Beyond Lactulose and Rifaximin
    Pronesti, Vincent
    Babich, Michael
    PRACTICAL GASTROENTEROLOGY, 2022, 46 (04) : 14 - 31
  • [40] RIFAXIMIN IN THE TREATMENT OF CHRONIC HEPATIC-ENCEPHALOPATHY
    PUXEDDU, A
    QUARTINI, M
    MASSIMETTI, A
    FERRIERI, A
    CURRENT MEDICAL RESEARCH AND OPINION, 1995, 13 (05) : 274 - 281
12345